AbbVie (ABBV) Finished Goods (2012 - 2016)
AbbVie (ABBV) reported Finished Goods of $556.0 million for Q2 2016, up 16.32% year-over-year from $478.0 million in Q3 2015, and up 0.72% on a QoQ basis from $552.0 million in Q1 2016.
AbbVie (ABBV) has 5 years of Finished Goods data on file, last reported at $556.0 million in Q2 2016.
- Quarterly Finished Goods rose 16.32% year-over-year to $556.0 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $556.0 million (up 16.32% YoY) and the FY2015 annual result came in at $469.0 million, up 37.54% from the prior year.
- Finished Goods advanced to $556.0 million in Q2 2016 per ABBV's latest filing, from $552.0 million in the prior quarter.
- Across five years, Finished Goods topped out at $640.0 million in Q3 2015 and bottomed at $280.0 million in Q3 2014.
- The 5-year median for Finished Goods is $485.0 million (2013), against an average of $479.5 million.
- The widest annual swing landed in 2014, when Finished Goods slumped 41.42%; it then surged 128.57% in 2015.
- Tracing ABBV's Finished Goods over 5 years: stood at $547.0 million in 2012, then decreased by 11.33% to $485.0 million in 2013, then fell by 29.69% to $341.0 million in 2014, then jumped by 37.54% to $469.0 million in 2015, then grew by 18.55% to $556.0 million in 2016.
- Per Business Quant, the three latest ABBV Finished Goods figures stand at $556.0 million (Q2 2016), $552.0 million (Q1 2016), and $469.0 million (Q4 2015).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 556.00 Mn |
| Mar 31, 2016 | 552.00 Mn |
| Dec 31, 2015 | 469.00 Mn |
| Sep 30, 2015 | 640.00 Mn |
| Jun 30, 2015 | 478.00 Mn |
| Mar 31, 2015 | 291.00 Mn |
| Dec 31, 2014 | 341.00 Mn |
| Sep 30, 2014 | 280.00 Mn |
| Dec 31, 2013 | 485.00 Mn |
| Sep 30, 2013 | 478.00 Mn |
| Jun 30, 2013 | 504.00 Mn |
| Mar 31, 2013 | 613.00 Mn |
| Dec 31, 2012 | 547.00 Mn |